L-Selectin Is Not Required for T Cell-Mediated Autoimmune Diabetes

  • Friedline R
  • Wong C
  • Steeber D
  • et al.
22Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Administration of anti-L-selectin (CD62L) mAb to neonatal nonobese diabetic (NOD) mice mediates long term protection against the development of insulitis and overt diabetes. These results suggested that CD62L has a key role in the general function of β cell-specific T cells. To further examine the role of CD62L in the development of type 1 diabetes, NOD mice lacking CD62L were established. The onset and frequency of overt diabetes were equivalent among CD62L+/+, CD62L+/−, and CD62L−/− NOD littermates. Furthermore, patterns of T cell activation, migration, and β cell-specific reactivity were similar in NOD mice of all three genotypes. Adoptive transfer experiments with CD62L−/− CD4+ T cells prepared from BDC2.5 TCR transgenic mice revealed no apparent defects in migration to pancreatic lymph nodes, proliferation in response to β cell Ag, or induction of diabetes in NOD.scid recipients. In conclusion, CD62L expression is not essential for the development of type 1 diabetes in NOD mice.

Cite

CITATION STYLE

APA

Friedline, R. H., Wong, C. P., Steeber, D. A., Tedder, T. F., & Tisch, R. (2002). L-Selectin Is Not Required for T Cell-Mediated Autoimmune Diabetes. The Journal of Immunology, 168(6), 2659–2666. https://doi.org/10.4049/jimmunol.168.6.2659

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free